
Keywords: anticoagulation; antiplatelet; antithrombotic therapy; peripheral artery disease; risk reduction; ABI; ankle-brachial index; HR; hazard ratio; MACCE; major adverse cardiovascular or cerebrovascular events; MALE; major adverse limb events; NNT; number need